Abstract

IntroductionDeep brain stimulation (DBS) has become a standard treatment option for select patients with Parkinson’s disease (PD). The selection process and surgical procedures employed have, to date, not been standardized.MethodsA comprehensive 58-question web-based survey was developed with a focus on DBS referral practices and peri-operative management. The survey was distributed to the Parkinson’s Foundation Centers of Excellence, members of the International Parkinson’s Disease and Movement Disorders Society, and the Parkinson Study Group (Functional Neurosurgery Working Group) between December 2015 and May 2016.ResultsThere were 207 individual respondents (20% response rate) drawn from 59 countries and 6 continents, of whom 64% received formal training in DBS. Thirteen percent of centers reported that DBS could proceed despite a confidence level of < 50% for PD diagnosis. A case-based approach to DBS candidacy was applied in 51.3% of centers without a cut-off for levodopa-responsiveness. Surprisingly, 33% of centers regularly used imaging for diagnostic confirmation of idiopathic PD. Thirty-one percent of centers reported that neuropsychological evaluation did not affect DBS target selection. Approximately half of the respondents reported determination of DBS candidacy based on a multidisciplinary committee evaluation and 1/3rd reported that a committee was used for target selection. Eight percent of respondents felt that psychosocial factors should not impact DBS candidacy nor site selection. Involvement of allied health professionals in the preoperative process was sparse. There was high variability in preoperative education about DBS outcome expectations. Approximately half of the respondents did not utilize a “default brain target,” though STN was used more commonly than GPi. Specific DBS procedure techniques applied, as well as follow-up timelines, were highly variable.ConclusionResults revealed high variability on the best approaches for DBS candidate selection, brain target selection, procedure type, and postoperative practices. Cognitive and mood assessments were underutilized. There was low reliance on multidisciplinary teams or psychosocial factors to impact the decision-making process. There were small but significant differences in practice across global regions, especially regarding multidisciplinary teams. The wide variability of responses across multiple facets of DBS care highlights the need for prospective studies to inform evidence-based guidelines.

Highlights

  • Deep brain stimulation (DBS) has become a standard treatment option for select patients with Parkinson’s disease (PD)

  • deep brain stimulation (DBS) has been recognized as a treatment of choice for specific symptoms by several national and international guideline committees and expert consensus

  • Fifty-eight (58%) of respondents classified themselves as movement disorders neurologists (MDN) and 15% as neurosurgeons (Supplementary File 2)

Read more

Summary

Introduction

Deep brain stimulation (DBS) has become a standard treatment option for select patients with Parkinson’s disease (PD). Parkinson’s disease (PD) is a progressive neurodegenerative disorder with both motor and non-motor symptoms and medical and surgical treatment options (Hughes et al, 1992; Postuma et al, 2015). There are many approved medications for PD symptoms, select patients may require deep brain stimulation (DBS) surgery (Lozano et al, 2019; Ramirez-Zamora et al, 2019). DBS has been included in several professional society best-practices recommendations (National Collaborating Centre for Chronic Conditions, 2006; Pahwa et al, 2006; Fox et al, 2011; Ferreira et al, 2013)

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call